AI

Streamlining Clinical Trials with AI

A clinical trial involves a set of complex processes, which include writing the protocol, recruiting patients, conducting the study, and culminating in bringing the drug to market. There are many stakeholders involved, in different capacities, to carry out these processes, ensure adherence to regulations, and keep the trial on track. Here are some of the…

Read More

Saama SVP for Marketing Karim Damji writes for PharmaExec.com

An essential defense strategy of the ancient times, moats have now transformed from a physical to a virtual form to suit today’s corporate castles. Karim Damji, Saama’s Senior Vice President of Marketing recently wrote on this very aspect of “Creating Defensible Data Analytics Moats for a Competitive Advantage” in his article for PharmaExec.com. Further in his…

Read More

Saama Mentioned in PM360 Article on AI

Meet Jose Andrade, president of InGaugement LLC, as he shares his thoughts on the impact of AI in healthcare. Featured in the PM360 magazine, his article mentions Saama as one of the innovators who is utilizing AI to accelerate the clinical trial process. He discusses the direction in which AI is headed in healthcare while…

Read More

AI Innovation for Life Science and Healthcare Summit- June 13-14

Samma - AI innovation Summit

Date: June 13-14, 2018 Venue: Sonesta Hotel Philadelphia 1800 Market Street Philadelphia, PA 19103 Malaikannan Sankarasubbu  VP of AI Research, Saama Technologies is speaking on June 13th at 12:30pm. Pharma has a Big Data Problem but an Even Bigger Text Problem Broad perspective on different Natural Language Processing (NLP) problems in Pharma and how that compares with other industries…

Read More

Saama’s DaLIA makes the headlines in Outsourcing Pharma

Latest from the Saama think tank comes DaLIA, an AI-informed virtual assistant aimed at delivering the next-level Life Science experience. Our VP for AI, Malaikannan Sankarsubbu speaks to Outsourcing Pharma about DaLIA and its constructive disruption. Read the news here.

Read More

Saama Launches Deep Learning Intelligent Assistant (DaLIA) to Solve Clinical Development Pain Points

AI-Informed Virtual Assistant Elevates Functionality of Existing Clinical Trial Solutions CAMPBELL, CA – (June 11, 2018) – Saama Technologies, Inc., a leading data analytics company, today announced the launch of a unique set of Artificial Intelligence (AI) capabilities specifically designed to alleviate the planning, feasibility and conduct challenges inherent in and pervasive throughout the drug…

Read More

Quantization and the Need for TPUs

Archana dives into the world of TPUs and discusses quantization, the process that is really responsible for making predictions in a neural network, lending a magical touch to the machine learning process. Read on to understand how quantization can be both a boon and a bane, depending on where it is used.

Read More

An Attentive Sequence Model for Adverse Drug Event Extraction from Biomedical Text

Adverse reaction caused by drugs is a potentially dangerous problem which may lead to mortality and morbidity in patients. Adverse Drug Event (ADE) extraction is a significant problem in biomedical research. We model ADE extraction as a Question-Answering problem and take inspiration from Machine Reading Comprehension (MRC) literature, to design our model. Our objective in…

Read More

Related Posts